SYNDAX PHARMACEUTICALS, INC. Common Stock (par value $0.0001 per share) SALES AGREEMENTSales Agreement • March 22nd, 2021 • Syndax Pharmaceuticals Inc • Pharmaceutical preparations • New York
Syndax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
